Alogabat
Product Specifications
Product Name Alternative
RG-7816; RO-7017773
UNSPSC Description
Alogabat (example 8) is a GABAA α5 receptor positive allosteric modulators (PAMs) (extracted from patent WO2018104419A1)[1].
Target Antigen
GABA Receptor
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel;Neuronal Signaling
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/alogabat.html
Purity
99.93
Solubility
DMSO : 33.33 mg/mL (ultrasonic)
Smiles
O=C(C1=NN=C(OCC2=C(C)ON=C2C3=CC=C(C)N=C3)C=C1)NC4CCOCC4
Molecular Weight
409.44
References & Citations
[1]Bernd Buettelmann, et al. New isoxazolyl ether derivatives as gaba a alpha5 pam. Patent WO2018104419A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-132806/Alogabat-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-132806/Alogabat-SDS-MedChemExpress.pdf
Clinical Information
Phase 2
CAS Number
2230009-48-8
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
DLEC1, ID (DLEC1, DLC1, Deleted in lung and esophageal cancer protein 1, Deleted in lung cancer protein 1) (MaxLight 405)
DLEC1, ID (DLEC1, DLC1, Deleted in lung and esophageal cancer protein 1, Deleted in lung cancer protein 1) (MaxLight 405)
S- (Trifluoromethyl) 4- (1,1-dimethylethyl) benzenecarbothioate
